M. Val Toledo-Lobo

707 total citations
31 papers, 531 citations indexed

About

M. Val Toledo-Lobo is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, M. Val Toledo-Lobo has authored 31 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in M. Val Toledo-Lobo's work include Cancer, Hypoxia, and Metabolism (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). M. Val Toledo-Lobo is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). M. Val Toledo-Lobo collaborates with scholars based in Spain, United Kingdom and Belgium. M. Val Toledo-Lobo's co-authors include Diego Gómez‐Coronado, Miguel A. Lasunción, Carlos Fernández, Santiago Casado, Carlos Luis Paı́no, Silvia Sacristán, Antonio Chiloeches, J.C. Angulo, Santiago Ropero and Fernando Arias and has published in prestigious journals such as Cancer, Scientific Reports and Neuroscience.

In The Last Decade

M. Val Toledo-Lobo

31 papers receiving 527 citations

Peers

Countries citing papers authored by M. Val Toledo-Lobo

Since Specialization

Citations

This map shows the geographic impact of M. Val Toledo-Lobo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Val Toledo-Lobo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Val Toledo-Lobo more than expected).

Fields of papers citing papers by M. Val Toledo-Lobo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Val Toledo-Lobo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Val Toledo-Lobo. The network helps show where M. Val Toledo-Lobo may publish in the future.

Co-authorship network of co-authors of M. Val Toledo-Lobo

This figure shows the co-authorship network connecting the top 25 collaborators of M. Val Toledo-Lobo. A scholar is included among the top collaborators of M. Val Toledo-Lobo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Val Toledo-Lobo. M. Val Toledo-Lobo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Histopathological Clues of Enhanced Inflammation in the Placental Tissue of Women with Chronic Venous Disease in Lower Limbs during Pregnancy 2024 ·Journal of Personalized Medicine ·(unknown), Óscar Fraile-Martínez, Cielo García‐Montero, M. Val Toledo-Lobo, Luis G. Guijarro, Juan A. De León-Luis, Coral Bravo, Raúl Dı́az, Laura López-González, Miguel A. Sáez, Melchor Álvarez‐Mon, Natalio Garcı́a-Honduvilla, Miguel Á. Ortega	2
2	Prognostic Value of Histone Acetyl Transferase 1 (HAT-1) and Inflammatory Signatures in Pancreatic Cancer 2024 ·Current Issues in Molecular Biology ·Miguel Á. Ortega, (unknown), Óscar Fraile-Martínez, Cielo García‐Montero, Luis G. Guijarro, Leonel Pekarek, Silvestra Barrena-Blázquez, Ángel Asúnsolo, Laura López-González, M. Val Toledo-Lobo, Melchor Álvarez‐Mon, Miguel A. Sáez, Alberto Gutiérrez‐Calvo, Raúl Dı́az	3
3	Abnormal Histopathological Expression of Klotho, Ferroptosis, and Circadian Clock Regulators in Pancreatic Ductal Adenocarcinoma: Prognostic Implications and Correlation Analyses 2024 ·Biomolecules ·Cielo García‐Montero, Óscar Fraile-Martínez, (unknown), Diego De León-Oliva, Diego Liviu Boaru, (unknown), (unknown), (unknown), (unknown), Luis G. Guijarro, M. Val Toledo-Lobo, Laura López-González, Raúl Dı́az, Jorge Monserrat, Melchor Álvarez‐Mon, Miguel A. Sáez, Miguel Á. Ortega	4
4	Is Insulin Receptor Substrate4 (IRS4) a Platform Involved in the Activation of Several Oncogenes? 2023 ·Cancers ·Luis G. Guijarro, (unknown), Diego Liviu Boaru, (unknown), Diego De León-Oliva, Óscar Fraile-Martínez, Cielo García‐Montero, Melchor Álvarez‐Mon, M. Val Toledo-Lobo, Miguel Á. Ortega	4
5	Chronic Venous Disease during Pregnancy Is Related to Inflammation of the Umbilical Cord: Role of Allograft Inflammatory Factor 1 (AIF-1) and Interleukins 10 (IL-10), IL-12 and IL-18 2023 ·Journal of Personalized Medicine ·Lara Sánchez‐Trujillo, Óscar Fraile-Martínez, Cielo García‐Montero, (unknown), Luis G. Guijarro, Diego De León-Oliva, Diego Liviu Boaru, (unknown), M. Val Toledo-Lobo, Mar Royuela, Ignacio García‐Tuñón, (unknown), Juan A. De León-Luis, Coral Bravo, Melchor Álvarez‐Mon, Julia Buján, Miguel A. Sáez, Natalio Garcı́a-Honduvilla, Miguel Á. Ortega	6
6	Understanding HAT1: A Comprehensive Review of Noncanonical Roles and Connection with Disease 2023 ·Genes ·Miguel Á. Ortega, Diego De León-Oliva, Cielo García‐Montero, Óscar Fraile-Martínez, Diego Liviu Boaru, M. Val Toledo-Lobo, Ignacio García‐Tuñón, Mar Royuela, Natalio Garcı́a-Honduvilla, Julia Buján, Luis G. Guijarro, Melchor Álvarez‐Mon, Miguel Ángel Álvarez-Mon	13
7	Protein kinase D activity is a risk biomarker in prostate cancer that drives cell invasion by a Snail/ERK dependent mechanism 2023 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·(unknown), M. Val Toledo-Lobo, (unknown), Pablo Baquero, J.C. Angulo, Antonio Chiloeches, Teresa Iglesias, Marina Lasa	2
8	Potential Therapeutic Use of Aptamers against HAT1 in Lung Cancer 2022 ·Cancers ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Eulalia Rodrı́guez-Martı́n, M. Val Toledo-Lobo, Vı́ctor M. González, M. Elena Martı́n	7
9	Oligodendroglia Generated From Adult Rat Adipose Tissue by Direct Cell Conversion 2022 ·Frontiers in Cell and Developmental Biology ·(unknown), (unknown), María Paz Muñoz, José Antonio Rodríguez‐Navarro, Daniel González‐Nieto, Luis C. Barrio, M. Val Toledo-Lobo, Carlos Luis Paı́no	2
10	Possible Role of IRS-4 in the Origin of Multifocal Hepatocellular Carcinoma 2021 ·Cancers ·Luis G. Guijarro, (unknown), Eva P. Cuevas, M. Val Toledo-Lobo, Jorge Monserrat, (unknown), Miguel A. Sáez, Miguel Ángel Álvarez-Mon, Julia Buján, Fernando Noguerales-Fraguas, E. Arilla, Melchor Álvarez‐Mon, Miguel Á. Ortega	11
11	Actinomycin D Arrests Cell Cycle of Hepatocellular Carcinoma Cell Lines and Induces p53-Dependent Cell Death: A Study of the Molecular Mechanism Involved in the Protective Effect of IRS-4 2021 ·Pharmaceuticals ·Luis G. Guijarro, (unknown), Eva P. Cuevas, M. Val Toledo-Lobo, Jorge Monserrat, (unknown), Miguel A. Sáez, Miguel Ángel Álvarez-Mon, Julia Buján, Fernando Noguerales-Fraguas, E. Arilla, Melchor Álvarez‐Mon, Miguel Á. Ortega	8
12	Impact of global PTP1B deficiency on the gut barrier permeability during NASH in mice 2020 ·Molecular Metabolism ·(unknown), Marta Puerto, (unknown), Van B. Lu, Irma García‐Martinez, (unknown), (unknown), M. Val Toledo-Lobo, Jorge Sáiz, Francisco J. Rupérez, Coral Barbas, Luís Menchén, Fiona M. Gribble, Frank Reimann, Luis G. Guijarro, J.M. Carrascosa, Ángela M. Valverde	14
13	Insulin receptor substrate-4 is overexpressed in colorectal cancer and promotes retinoblastoma–cyclin-dependent kinase activation 2018 ·Journal of Gastroenterology ·(unknown), M. Val Toledo-Lobo, Fernando Noguerales-Fraguas, (unknown), Antonio Jiménez-Ruı́z, Luis G. Guijarro	13
14	Dynamics of plasma membrane surface related to the release of extracellular vesicles by mesenchymal stem cells in culture 2017 ·Scientific Reports ·Santiago Casado, M. Val Toledo-Lobo, Carlos Luis Paı́no	42
15	Reduction in Aβ‐induced cell death in the hippocampus of 17β‐estradiol‐treated female rats is associated with an increase in IGF‐I signaling and somatostatinergic tone 2015 ·Journal of Neurochemistry ·(unknown), (unknown), David Aguado‐Llera, Laura M. Frago, M. Val Toledo-Lobo, Iván Carrera, Ramón Cacabelos, Julie A. Chowen, Jesús Argente, (unknown), Vicente Barrios	12
16	Dual specificity phosphatase 1 expression inversely correlates with NF‐κB activity and expression in prostate cancer and promotes apoptosis through a p38 MAPK dependent mechanism 2013 ·Molecular Oncology ·(unknown), M. Val Toledo-Lobo, María Teresa Gutiérrez‐Salmerón, (unknown), Santiago Ropero, J.C. Angulo, Antonio Chiloeches, Marina Lasa	57
17	Acute up-regulation of the rat brain somatostatin receptor-effector system by leptin is related to activation of insulin signaling and may counteract central leptin actions 2013 ·Neuroscience ·(unknown), Emma Burgos‐Ramos, (unknown), (unknown), Laura M. Frago, América Hervás‐Aguilar, Sergio de Frutos, M. Val Toledo-Lobo, Virginia Mela, María‐Paz Viveros, Jesús Argente, Julie A. Chowen, E. Arilla, Vicente Barrios	8
18	Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer 2009 ·Cancer ·Enrique Carrillo de Santa Pau, Fernando Arias, Enrique Caso, Gemma María Muñoz‐Molina, (unknown), (unknown), (unknown), Silvia Sacristán, (unknown), M. Val Toledo-Lobo	81
19	Cholesterol is essential for mitosis progression and its deficiency induces polyploid cell formation 2004 ·Experimental Cell Research ·Carlos Fernández, M. Val Toledo-Lobo, Diego Gómez‐Coronado, Miguel A. Lasunción	114
20	Localization of eukaryotic initiation factor 2 in neuron primary cultures and established cell lines 1997 ·The Histochemical Journal ·M. Val Toledo-Lobo, F. Javier M. Alonso, (unknown), (unknown), M. Elena Martı́n, (unknown), (unknown), Matilde Salinas, Juan L. Fando	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact